Skip to Content

Join the 'Bipolar Disorder' group to help and get support from people like you.

Bipolar Disorder News

Related terms: Bipolar Affective Disorder, Bipolar Affective Mood Disorder, Bipolar I Disorder, Manic Depression, Manic Depressive Disorder, Manic Depressive Illness, Mood Disorder, Bipolar, Bipolar Depression, Ultra Rapid Cycling, Bipolar II Disorder

Certain Teens More Likely to Get Hooked on Opioids

Posted 12 Mar 2018 by Drugs.com

MONDAY, March 12, 2018 – Teenagers with any mental health problem are more prone to painkiller dependence after receiving a prescription opioid, a new study finds. The odds of progressing to long-term opioid therapy can double, triple or more, depending on the kid's diagnosis and the other drugs prescribed to treat their disorder, the researchers said. The findings mirror earlier studies showing ...

FDA Approves Latuda (lurasidone HCl) for Bipolar Depression in Pediatric Patients (10 to 17 Years of Age)

Posted 12 Mar 2018 by Drugs.com

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- March 6, 2018 – Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) that expands the use of Latuda (lurasidone HCI) to include the treatment of major depressive episode associated with bipolar I disorder (bipolar depression) in pediatric patients (10 to ...

Autism, Bipolar and Schizophrenia Share Genetic Similarities

Posted 8 Feb 2018 by Drugs.com

THURSDAY, Feb. 8, 2018 – By examining brain tissue, researchers say they've found similarities in certain mental illnesses, including autism and schizophrenia. Specifically, some similar patterns of gene expression were found in people with autism, schizophrenia and bipolar disorder, the researchers say. Gene expression refers to cells' conversion of genetic instructions into proteins. "These ...

FDA Approves Abilify MyCite (aripiprazole) Pill with Sensor to Digitally Track if Patients Have Ingested Their Medication

Posted 14 Nov 2017 by Drugs.com

November 13, 2017 – The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated ...

FDA OKs First 'Digital Pill', Abilify Mycite, That Lets Doctors Know It's Been Taken

Posted 14 Nov 2017 by Drugs.com

TUESDAY, Nov. 14, 2017 – Offering both the promise of better patient compliance with health care, but also fears of a medical "Big Brother," a newly approved "digital pill" allows physicians to track whether or not it's been ingested by patients. The U.S. Food and Drug Administration has given the nod to Abilify MyCite, for use in patients with schizophrenia, an add-on treatment for depression, ...

'Digital Pill', Abilify Mycite, Tells Doctor When Patient Takes It

Posted 14 Nov 2017 by Drugs.com

TUESDAY, Nov. 14, 2017 – The first drug designed to alert a doctor when a patient takes the medication has been approved by the U.S. Food and Drug Administration. Abilify MyCite (aripiprazole with sensor) has an embedded sensor that sends a message to a wearable patch that the medication's been taken. This allows the patient and doctor to track the medication's use via smartphone. Abilify, first ...

Genes May Explain Why Some Don't Respond to Bipolar Drug

Posted 8 Nov 2017 by Drugs.com

WEDNESDAY, Nov. 8, 2017 – In a finding that pulls the roots of two mental illnesses closer together, researchers say people with bipolar disorder that's resistant to the drug lithium have a high number of genes associated with schizophrenia. Since the 1950s, lithium has been widely used to treat bipolar disorder. The drug stabilizes mood swings – the highs and lows associated with the disorder ...

Daily 'Light Therapy' May Help Some With Bipolar Disorder

Posted 12 Oct 2017 by Drugs.com

THURSDAY, Oct. 12, 2017 – People afflicted with bipolar disorder may find some relief from depression with daily doses of light therapy, new research suggests. With light therapy, people spend time sitting in close proximity to a light-emitting box – in this case, bright white light – with exposures increasing from 15 minutes per day to a full hour over a period of weeks. The study found that ...

Americans More Open About Mental Health Issues, But Stigma Lingers

Posted 3 Oct 2017 by Drugs.com

TUESDAY, Oct. 3, 2017 – Americans may be more willing to talk about mental health issues these days, but misperceptions and stigmas persist, a new survey finds. The survey, of more than 3,000 U.S. adults, found that 70 percent said they feel people are more open to discussing mental health compared with a decade ago. Most respondents also said they'd want to help a family member or friend ...

Parents Say Schools Don't Help Kids With Mental Health, Chronic Disease

Posted 18 Sep 2017 by Drugs.com

MONDAY, Sept. 18, 2017 – Many parents don't believe schools are prepared to help students with mental health problems and serious physical health issues, a new survey finds. While 77 percent of parents were certain that schools would be able to provide first aid for minor issues such as cuts, they were less confident that schools could respond to more challenging health situations. For example, ...

Health Tip: Mental Disorders Are Common

Posted 9 Aug 2017 by Drugs.com

-- More than 43 million American adults, 18 percent of the U.S. population, had a mental disorder in the past year, the most recent surveys cited by the Substance Abuse and Mental Health Services Administration (SAMHSA) show. These disorders – characterized by significant changes in mood, thoughts or behavior – often make carrying out daily activities more difficult and impair relationships ...

Abilify Maintena (aripiprazole) for Extended-Release Injectable Suspension Approved by the U.S. FDA for Maintenance Monotherapy Treatment of Bipolar I Disorder

Posted 8 Aug 2017 by Drugs.com

Valby, Denmark and Tokyo, Japan, 28 July 2017 - H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced Abilify Maintena® (aripiprazole) for extended-release injectable suspension was approved by the U.S. Food and Drug Administration for the maintenance monotherapy treatment of bipolar I disorder (BP I) in adults1. Abilify Maintena is a once-monthly injectable ...

Nearly 1 in 5 U.S. Adults Has Mental Illness or Drug Problem

Posted 21 Jul 2017 by Drugs.com

FRIDAY, July 21, 2017 – Nearly 1 in 5 American adults deals with a mental illness or substance abuse problem each year, a U.S. government study says. Oregon has the highest rate, and New Jersey the lowest, according to 2012-2014 data analyzed by the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA). Overall, almost 44 million Americans 18 or older had a diagnosable mental, ...

Poor Sleep May Worsen Suicidal Thoughts

Posted 28 Jun 2017 by Drugs.com

WEDNESDAY, June 28, 2017 – Sleep problems may provide early clues about worsening suicidal thoughts in at-risk young adults as well as a potential way to intervene, a new study suggests. "Suicide is the tragic outcome of psychiatric illness interacting with multiple biological, psychological and social risk factors," said lead author Rebecca Bernert. She is a suicidologist and assistant ...

Study Cites Top Reasons Young Autism Patients Are Hospitalized

Posted 16 Jun 2017 by Drugs.com

FRIDAY, June 16, 2017 – Having a mood disorder significantly boosts the odds that young people with autism will be hospitalized for psychiatric care, according to a new study. People with autism are often hospitalized when their behavior problems overwhelm their caregivers, the study authors said. "The demand is far greater than the number of clinicians, the number of programs and the number of ...

Page 1 2 3 4 5 6 7 8 9 Next

Ask a Question

Further Information

Related Condition Support Groups

Mania, Severe Mood Dysregulation, Cyclothymic Disorder, Disruptive Mood Dysregulation Disorder, Psychiatric Disorders

Related Drug Support Groups

gabapentin, clonazepam, Seroquel, citalopram, sertraline, Lamictal, Abilify, bupropion, lithium, view more... venlafaxine, Depakote, escitalopram, Latuda, lamotrigine, clonidine, risperidone, Zyprexa, quetiapine, topiramate, Risperdal, Geodon, Saphris, Seroquel XR, duloxetine, verapamil, carbamazepine, olanzapine, Depakote ER, levetiracetam, oxcarbazepine, aripiprazole, divalproex sodium, Vraylar, valproic acid, Symbyax, desvenlafaxine, perphenazine, armodafinil, ziprasidone, Zyprexa Zydis, Depakote Sprinkles, paliperidone, Risperdal Consta, asenapine, Eskalith, Lithobid, Equetro, Eskalith-CR, iloperidone, Abilify Maintena, Risperdal M-Tab, Lamictal ODT, Lamictal CD, lurasidone, Lithonate, Abilify Discmelt, Zyprexa Intramuscular, fluoxetine / olanzapine, Abilify MyCite, Lithotabs, cariprazine, tiagabine